Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. freshman Avg
|
|
New words:
AA, antidilutive, Arca, Argenta, bad, bioburden, Bulletin, Cancer, cardiac, Carlo, carryforward, Cayman, channel, ChanTest, Citigroup, CMI, collateralized, College, constrained, construction, coordinating, curve, cytology, DCP, deprecation, derecognized, dialog, dispersion, diversification, diversified, druggable, DSA, Dutch, EBITDA, elaborated, escalation, EU, feedback, fifteen, floating, folded, forma, formulation, Frederick, gastrointestinal, half, hit, Ida, immaterial, induced, insignificant, interact, invoiced, ion, ISO, lag, lattice, library, Maker, Maryland, methodology, mezzanine, microsampling, microscopy, mimicking, Monte, Mt, NCI, occasion, oligonucleotide, opposed, opposition, outreach, owner, pathogen, peer, perspective, pharmacodynamic, Pharmatech, platelet, pluripotent, PMO, postretirement, predominant, pro, PSU, psychotropic, purport, push, ready, reallocation, recalculate, recasting, redundancy, renegotiated, rental, reorganization, resolving, resurgence, retiree, safe, sequencing, simpler, situ, spot, standpoint, stay, sterility, survive, taxable, throughput, tissue, tool, trustee, unaudited, uncollectible, unlimited, unmarketable, unsecured, upstream, VivoPath, Watson, windfall
Removed:
AAALAC, accessible, accessing, accretion, actively, acute, adjusting, amortizing, annuity, AOCI, apparent, approximating, ASR, Assigning, attestation, balancing, bank, BC, billable, borrow, borrowed, branded, breakdown, centered, challenge, climate, closure, collectability, commencing, comparing, consisted, Conversely, conveyed, correlation, corroborated, cover, crediting, daily, dealing, decisive, depreciate, designate, disregarded, DNA, draft, DSO, EAFE, EMA, EPS, experienced, facilitate, feasible, Finland, fluctuation, forfeiture, fulfillment, furniture, genotoxicity, greatest, guaranteed, inception, indexed, informed, intent, judgmental, Lean, length, LIBOR, light, lived, machinery, margin, marketable, materiality, met, MHRA, microscopic, monoclonal, month, movement, MSCI, nominal, November, objection, occasionally, outlook, PCS, percent, perpetuity, placement, pledge, promotion, prospectively, protein, pursuit, ratably, readily, reassessment, recovery, reinvest, reinvestment, releasing, remeasure, restructured, resultant, returning, reverse, screen, secured, segregate, shortfall, Sigma, slower, SPC, sufficiently, summarize, suspended, sustained, thereon, tight, toxicity, transferred, treated, turnaround, twelve, type, unaffiliated, uncertainty, underutilized, unforeseen, unrealized, validating, verbal, VWAP, weight
Filing tables
Filing exhibits
Related press release
CRL similar filings
Filing view
External links
Exhibit 32.1
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the annual report on Form 10-K for the year ended December 27, 2014 of Charles River Laboratories International, Inc. (the “Company”) as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, James C. Foster, Chairman, Chief Executive Officer and President of the Company, and Thomas F. Ackerman, Chief Financial Officer of the Company, each hereby certifies, to the best of his knowledge and pursuant to 18 U.S.C. Section 1350, that:
| (1) | the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (the “Exchange Act”); and |
| (2) | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
| Dated: | February 17, 2015 | /s/ JAMES C. FOSTER | |
Chairman, President and Chief Executive Officer Charles River Laboratories International, Inc. | |||
| Dated: | February 17, 2015 | /s/ THOMAS F. ACKERMAN | |
Corporate Executive Vice President and Chief Financial Officer Charles River Laboratories International, Inc. | |||
This certification shall not be deemed "filed" for any purpose, nor shall it be deemed to be incorporated by reference into any filing under the Securities Act of 1933 or the Exchange Act.